-The Telegraph New Delhi: The Supreme Court today ticked off the government for "dilly dallying" on an affordable drug pricing policy, following a petition that said the delay was aimed at pushing through suggestions of the powerful manufacturers' lobby. A bench of Justices G.S. Singhvi and Gopala Gowda asked the Centre to respond within six weeks. The All India Drug Action Network (AIDAN) had filed the application saying the government was delaying a...
More »SEARCH RESULT
Total Matching Records found : 50
Social Justice
KEY TRENDS • According to National Sample Survey report no. 583: Persons with Disabilities in India, the percentage of persons with disability who received aid/help from Government was 21.8 percent, 1.8 percent received aid/help from organisation other than Government and another 76.4 percent did not receive aid/ help *8 • As per National Family Health Survey-4 (NFHS-4), the Under-five Mortality Rate (U5MR) was 57.2 per 1,000 live births (for the non-STs it was 38.5)...
More »European Union-India FTA may hit generic medical industry-Rema Nagarajan
-The Times of India The free trade agreement that European Union is pushing India to sign could put an end to India's status as the pharmacy of the developing providing affordable medicines, especially HIV drugs to countries like Brazil, Thailand, South Africa, Zimbabwe and several others. The negotiations with EU are on at a feverish pace this week in Brussels even before the parliamentary standing committee looking into the free trade...
More »The good, bad and ugly -Narayan Lakshman
-The Hindu There is little doubt that US universities have a long way to go in terms of making women safe on campus In the wake of the high-profile gang rape incident in New Delhi on December 16, media and public comments have significantly centred on anti-woman attitudes in Indian society, particularly among young men. This line of introspection is indeed warranted, for there can be little doubt that these values have fuelled...
More »SC to Examine New Drug Pricing Policy
-Outlook The Supreme Court today said it would examine the National Pharmaceutical Pricing Policy after it is notified with the Centre promising to do it within two weeks. A bench headed by Justice G S Singhvi granted two weeks time to the Centre to issue notification and posted the matter for hearing on December 12. Additional Solicitor General Siddharth Luthra informed the court that the Cabinet had approved the policy that will bring...
More »
